Related Experiment Video
Updated: Jul 5, 2026
09:26
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Gemifloxacin for community-acquired pneumonia
Hartmut M Lode1, Malina Schmidt-Ionas, Ralf Stahlmann
1RCMS, Hohenzollerndamm 2, Ecke Bundesallee, D-10717 Berlin-Wilmersdorf, Germany. haloheck@zedat.fu-berlin.de
Expert Opinion on Investigational Drugs
|May 2, 2008
Summary
Gemifloxacin shows superior activity against Streptococcus pneumoniae, a common cause of community-acquired pneumonia (CAP). This newer fluoroquinolone antibiotic is effective and well-tolerated for treating mild-to-moderate CAP.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Fluoroquinolones are key treatments for community-acquired pneumonia (CAP).
- Gemifloxacin is a newer fluoroquinolone demonstrating favorable outcomes in CAP treatment.
Purpose of the Study:
- To evaluate gemifloxacin's microbiological, pharmacokinetic/pharmacodynamic, and clinical activity in CAP.
- To review safety data from controlled clinical studies of gemifloxacin for CAP.
Main Methods:
- Systematic literature review of English publications.
- Analysis focused on studies within the last 10 years.
- Inclusion of all aspects of gemifloxacin's use in CAP.
Main Results:
- Gemifloxacin exhibits the highest in vitro activity against Streptococcus pneumoniae, the primary pathogen in CAP.
- Comparative studies demonstrate gemifloxacin's high efficacy in treating mild-to-moderate CAP.
- Gemifloxacin was well-tolerated in clinical studies for CAP.
Conclusions:
- Gemifloxacin is a potent fluoroquinolone against Streptococcus pneumoniae.
- It is an effective and safe option for mild-to-moderate community-acquired pneumonia.
- Clinical evidence supports gemifloxacin's favorable profile in CAP management.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...